The healthcare community is buzzing by retatrutide, a innovative dual GIP and GLP-1 receptor that’s showing significant results in early studies . This treatment works by replicating natural hormones to impact appetite and increase feelings of satiety, ultimately resulting in noticeable fat reduction . While presently under review and not broadly